Efficacy and safety of topiramate as add-on therapy in 50 Iranian children patients with intractable seizure disorder under the age of 2 years

被引：0
|
作者：
Fallah, A
Pakdaman, R
Pakdaman, H
机构：
[1] Beheshtee Univ, Tehran, Iran
[2] Univ Tehran, Tehran, Iran
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of efsubaglutide alfa as add-on to metformin in patients with type 2 diabetes
    Wang, Q.
    Bao, Y.
    Chen, S.
    Zhou, J.
    Anwar, D.
    Jia, W.
    DIABETOLOGIA, 2024, 67 : S358 - S358
  • [42] Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children
    Liu, Jiaojiao
    Han, Xinli
    Jiang, Xiaoyun
    Gao, Xia
    Li, Guomin
    Fang, Xiaoyan
    Chen, Jing
    Zhai, Yihui
    Liu, Jialu
    Pei, Yuxin
    Zhang, Jiayi
    Zhu, Guoqin
    Shen, Qian
    Xu, Hong
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 940 - 943
  • [43] Safety and efficacy of linagliptin as add-on therapy to a sulphonylurea in inadequately controlled type 2 diabetes
    Lewin, A. J.
    Arvay, L.
    Liu, D.
    Patel, S.
    Woerle, H. -J.
    DIABETOLOGIA, 2010, 53
  • [44] Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes
    Kadowaki, Takashi
    Inagaki, Nobuya
    Kondo, Kazuoki
    Nishimura, Kenichi
    Kaneko, Genki
    Maruyama, Nobuko
    Nakanishi, Nobuhiro
    Watanabe, Yumi
    Gouda, Maki
    Iijima, Hiroaki
    DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 77 - 84
  • [45] Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
    Duan, Weijia
    Ou, Xiaojuan
    Wang, Xiaoming
    Wang, Yu
    Zhao, Xinyan
    Wang, Qianyi
    Wu, Xiaoning
    Zhang, Wei
    Ma, Hong
    You, Hong
    Jia, Jidong
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2018, 110 (09) : 557 - 563
  • [46] EFFICACY AND SAFETY OF ZONISAMIDE AS FIRST ADD-ON THERAPY IN ADULT PATIENTS WITH PARTIAL, GENERALIZED & COMBINED SEIZURES
    Mehta, S. C.
    Shah, S.
    Mathur, V. N.
    Manjunath, N. C.
    Jyothi, B.
    Demudubabu, B.
    Kumar, V.
    Bajpai, V.
    Langade, D.
    Dash, A.
    EPILEPSIA, 2012, 53 : 50 - 50
  • [47] Safety and Efficacy of Tiotropium Respimat® Add-on Therapy in Pre-school Children with Symptomatic Persistent Asthma
    Vandewalker, Mark
    Bisgaard, Hans
    Vandewalker, Mark
    Harper, Thomas
    Rupp, Ned
    Moroni-Zentgraf, Petra
    El Azzi, Georges
    Engel, Michael
    Vulcu, Sebastian D.
    Finnigan, Helen
    Vrijlandt, Elianne J. L. E.
    PEDIATRICS, 2018, 141
  • [48] Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy
    Elanagan Nagarajan
    Timothy M. Lynch
    Bridget Frawley
    Marjorie E. Bunch
    Neurological Sciences, 2023, 44 : 2883 - 2888
  • [49] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    Diabetes Therapy, 2014, 5 : 169 - 181
  • [50] Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy
    Nagarajan, Elanagan
    Lynch, Timothy M.
    Frawley, Bridget
    Bunch, Marjorie E.
    NEUROLOGICAL SCIENCES, 2023, 44 (08) : 2883 - 2888
12345